Patent settlements: Ban or maybe tax instead?

The White House wants to ban settlements in patent litigation between brand name and generic pharmaceutical companies. These settlements occur when a generic company sues a company whose drug is on patent, challenging its validity. Sometimes the companies agree to settle, which typically results in some combination of a cash settlement and early introduction of [...]

Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/_E8l6Egv54Y/

discovery health channel arab health